SCHEMBL25017488

SCHEMBL25017488

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4sc5c(-c6nc(-c7cccc8c7sc7ccccc78)nc7c6oc6ccccc67)cccc5c34)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.40
ALDH1A1 P00352 8/20 0.39
TSHR P16473 5/20 0.39
KDM4E B2RXH2 3/20 0.39
POLB P06746 3/20 0.39
HPGD P15428 2/20 0.39
NPSR1 Q6W5P4 4/20 0.39
KMT2A Q03164 7/20 0.38
LMNA P02545 5/20 0.38
HSD17B10 Q99714 3/20 0.38
USP2 O75604 1/20 0.38
HTT P42858 1/20 0.38
MEN1 O00255 6/20 0.38
MAPK1 P28482 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
GAA P10253 2/20 0.37
ALOX12 P18054 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25016616 1.00 MAPT (0.40) MAPTALDH1A1TSHRKDM4EPOLB
SCHEMBL25017772 1.00 MAPT (0.40) MAPTALDH1A1TSHRKDM4EPOLB
SCHEMBL22195669 0.97 MAPT (0.41) MAPTALDH1A1TSHRKDM4EPOLB
SCHEMBL25016739 0.97 MAPT (0.41) MAPTALDH1A1TSHRKDM4EPOLB
SCHEMBL22330127 0.96 MAPT (0.43) MAPTALDH1A1TSHRKDM4EPOLB
SCHEMBL25016947 0.95 MAPT (0.41) MAPTALDH1A1TSHRKDM4EPOLB
SCHEMBL25016211 0.95 MAPT (0.41) MAPTALDH1A1TSHRKDM4EPOLB
SCHEMBL25016945 0.94 ALOX5 (0.38) MAPTALDH1A1TSHRKDM4EPOLB
SCHEMBL25017189 0.94 MAPT (0.41) MAPTALDH1A1TSHRKDM4EPOLB
SCHEMBL25016923 0.94 MAPT (0.41) MAPTALDH1A1TSHRKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11578076-B2 Heterocyclic compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2023-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578076-B2 Heterocyclic compound and organic light emitting device using the same CYBA, SUN2, TMEM109 MAPT 1736/4885ALDH1A1 195/4885TSHR 4683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.